Select Medical Misses Q4 Estimates with 16¢ EPS on $1.4B Revenue
Select Medical reported Q4 profit of $20.2 million (EPS $0.16) on $1.4 billion revenue, missing analyst estimates of $0.23 per share. The company recorded full-year profit of $146.2 million ($1.16 per share) on $5.45 billion revenue and forecasts 2026 EPS of $1.22–1.32 and revenue of $5.6–5.8 billion.
1. Q4 Financial Results
Select Medical posted Q4 net profit of $20.2 million, or $0.16 per share, below the $0.23 consensus estimate. Revenue reached $1.4 billion, reflecting solid demand but offset by rising operating costs that compressed margins.
2. Full-Year Performance
For the full year, the company generated $146.2 million in net profit, or $1.16 per share, on $5.45 billion in revenue. Annual revenue held near prior levels while earnings increased modestly year over year.
3. 2026 Guidance
Management expects 2026 EPS between $1.22 and $1.32 and revenue of $5.6–5.8 billion, indicating modest top-line growth and margin improvement prospects for the coming year.